Zimmer Biomet Holdings Knees — Revenue decreased by 9.1% to $828.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.5%, from $792.90M to $828.60M. Over 4 years (FY 2021 to FY 2025), Knees — Revenue shows an upward trend with a 5.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growing market share, successful product adoption, or higher procedure volumes, while a decrease may signal competitive pressure, pricing erosion, or a slowdown in elective surgical procedures.
This metric represents the total net sales generated from the sale of knee reconstructive implants and related surgical...
Peers in the medical device sector report this as 'Knee Reconstruction Revenue' or 'Joint Replacement Segment Sales', typically benchmarked against overall orthopedic market growth rates.
zbh_segment_knees_revenue_from_contract_with_customer_excluding_assessed_tax| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $665.60M | $647.90M | $720.10M | $662.80M | $704.90M | $657.00M | $753.60M | $762.50M | $771.40M | $706.30M | $798.30M | $788.10M | $801.10M | $745.10M | $839.20M | $792.90M | $826.00M | $792.40M | $911.10M | $828.60M |
| QoQ Change | — | -2.7% | +11.1% | -8.0% | +6.4% | -6.8% | +14.7% | +1.2% | +1.2% | -8.4% | +13.0% | -1.3% | +1.6% | -7.0% | +12.6% | -5.5% | +4.2% | -4.1% | +15.0% | -9.1% |
| YoY Change | — | — | — | — | +5.9% | +1.4% | +4.7% | +15.0% | +9.4% | +7.5% | +5.9% | +3.4% | +3.9% | +5.5% | +5.1% | +0.6% | +3.1% | +6.3% | +8.6% | +4.5% |